NewYork-Presbyterian Hospital/Weill Cornell Medical Center is conducting the first clinical trial to test surgery for Type 2 Diabetes in overweight or mildly obese patients, according to a news release.
The study will compare gastric bypass surgery to other medical treatment for diabetes in patients with a body mass index between 26 and 35, inclusive. Patients will receive either Roux-en-Y Gastric Bypass surgery or traditional medical therapy, and all will learn lifestyle modification techniques including diet and exercise.
Previous research has studied gastric bypass as a treatment for Type 2 Diabetes in severely obese patients — those who have a BMI over 35. These tests have been effective in improving blood glucose levels and lowering the need for medication and risk for diabetes-related death.
Read the release on the clinical trial.
Read more coverage on gastric bypass surgery:
- South Carolina to Cover 100 Obesity Surgeries Under Pilot Program
- Pittsburgh's West Penn Bariatric Surgery Center Earns ACS Accreditation
- Study: Gastric Bypass Patients at Higher Risk for Kidney Stones After the Procedure
The study will compare gastric bypass surgery to other medical treatment for diabetes in patients with a body mass index between 26 and 35, inclusive. Patients will receive either Roux-en-Y Gastric Bypass surgery or traditional medical therapy, and all will learn lifestyle modification techniques including diet and exercise.
Previous research has studied gastric bypass as a treatment for Type 2 Diabetes in severely obese patients — those who have a BMI over 35. These tests have been effective in improving blood glucose levels and lowering the need for medication and risk for diabetes-related death.
Read the release on the clinical trial.
Read more coverage on gastric bypass surgery:
- South Carolina to Cover 100 Obesity Surgeries Under Pilot Program
- Pittsburgh's West Penn Bariatric Surgery Center Earns ACS Accreditation
- Study: Gastric Bypass Patients at Higher Risk for Kidney Stones After the Procedure